| NCT03056924 |
Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab |
https://ClinicalTrials.gov/show/NCT03056924 |
Completed |
Boston Medical Center |
2019-01-15 |
| NCT03396458 |
Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg |
https://ClinicalTrials.gov/show/NCT03396458 |
Recruiting |
Hasselt University |
2020-08-31 |
| NCT01734018 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01734018 |
Completed |
Hoffmann-La Roche |
2012-08-31 |
| NCT03825458 |
Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. |
https://ClinicalTrials.gov/show/NCT03825458 |
Recruiting |
Hospices Civils de Lyon |
2022-10-31 |
| NCT03358108 |
A Prospective,Observational Follow-up Study of Nucleoside Treated Patients With Chronic Hepatitis B (OCEAN Study) |
https://ClinicalTrials.gov/show/NCT03358108 |
Recruiting |
Tongji Hospital |
2020-12-01 |
| NCT03329820 |
Quality of Life and Health Utility of Patients With CHB Infections |
https://ClinicalTrials.gov/show/NCT03329820 |
Completed |
The University of Hong Kong |
2009-06-30 |
| NCT03300414 |
Biologic Basis of Liver Cancer From Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03300414 |
Completed |
University of California, Davis |
2018-12-14 |
| NCT03248622 |
Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection |
https://ClinicalTrials.gov/show/NCT03248622 |
Completed |
National Institutes of Health Clinical Center (CC) |
2019-05-28 |
| NCT03221049 |
Radiomics for Diagnosing Liver Diseases and Evaluating Progression |
https://ClinicalTrials.gov/show/NCT03221049 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2022-12-31 |
| NCT03215732 |
Cross Sectional Survey on the Burden and Impacts of Chronic Hepatitis B in the Rural Area of Niakhar, Senegal |
https://ClinicalTrials.gov/show/NCT03215732 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2019-07-31 |
| NCT03181607 |
Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV |
https://ClinicalTrials.gov/show/NCT03181607 |
Enrolling by invitation |
The Third Affiliated Hospital of Guangzhou Medical University |
2019-05-26 |
| NCT03158818 |
Chronic Hepatitis B Virus Infection in Zambia |
https://ClinicalTrials.gov/show/NCT03158818 |
Recruiting |
University of Alabama at Birmingham |
2021-01-31 |
| NCT03149627 |
Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults |
https://ClinicalTrials.gov/show/NCT03149627 |
Completed |
University of Alabama at Birmingham |
2018-12-19 |
| NCT03097952 |
“Real-life” Cohort Study on Patients With Chronic HBV Infection in Jiangsu |
https://ClinicalTrials.gov/show/NCT03097952 |
Recruiting |
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
2030-12-31 |
| NCT03088995 |
Pilot Study of HIV and Hepatitis B and C Screening in Surgery |
https://ClinicalTrials.gov/show/NCT03088995 |
Completed |
Centre de Recherches et d’Etude sur la Pathologie Tropicale et le Sida |
2017-09-01 |
| NCT03042481 |
Off-therapy Response After Stopping Entecavir or Tenofovir |
https://ClinicalTrials.gov/show/NCT03042481 |
Recruiting |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2019-05-31 |
| NCT02995252 |
The HOPE Study: Characterizing Patients With Hepatitis B and C |
https://ClinicalTrials.gov/show/NCT02995252 |
Recruiting |
University of Maryland, Baltimore |
2020-01-31 |
| NCT02985450 |
A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada |
https://ClinicalTrials.gov/show/NCT02985450 |
Recruiting |
University of Calgary |
2019-12-31 |
| NCT02974829 |
REALM China Extension Study |
https://ClinicalTrials.gov/show/NCT02974829 |
Recruiting |
Nanfang Hospital of Southern Medical University |
2022-01-31 |
| NCT02909023 |
Performance of the HBV ELISPOT in the Detection of the T Cellular Immune Response in Patients Infected by HBV or Cured |
https://ClinicalTrials.gov/show/NCT02909023 |
Completed |
Hospices Civils de Lyon |
2016-09-30 |
| NCT02877589 |
Interest of Routine Screening for Hepatitis B and C in Patients Receiving Chemotherapy for Solid Tumors |
https://ClinicalTrials.gov/show/NCT02877589 |
Completed |
CHU de Reims |
2013-07-31 |
| NCT02876419 |
A Long Term Follow-up Study of Patients From the REP 301 Protocol |
https://ClinicalTrials.gov/show/NCT02876419 |
Active, not recruiting |
Replicor Inc. |
2019-11-13 |
| NCT02863757 |
Follow-up of Chronic Hepatitis B Patients With Comorbid Nonalcoholic Fatty Liver Disease |
https://ClinicalTrials.gov/show/NCT02863757 |
Recruiting |
Humanity and Health Research Centre |
2026-12-31 |
| NCT02791386 |
Rescue Treatment Pattern, Drug Resistance Recurrence, and Direct Medical Costs Associated With Chinese Patients With Chronic Hepatitis B and Drug Resistance to Nucleot(s)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT02791386 |
Completed |
Bristol-Myers Squibb |
2017-10-30 |
| NCT02785835 |
Hepatocellular Carcinoma in HIV-infected Patients |
https://ClinicalTrials.gov/show/NCT02785835 |
Recruiting |
Hospital Universitario de Valme |
2016-12-31 |
| NCT02749864 |
Study to Evaluate the Prevalence of Hepatitis C in Spain in 2015 (PREVHEP) |
https://ClinicalTrials.gov/show/NCT02749864 |
Completed |
Instituto de Investigación Marqués de Valdecilla |
2017-04-01 |
| NCT02719808 |
Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection |
https://ClinicalTrials.gov/show/NCT02719808 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2022-12-31 |
| NCT02582333 |
Clinical Course Study in Chronic Hepatitis B After Nucleos(t)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT02582333 |
Recruiting |
Taichung Veterans General Hospital |
2020-10-31 |
| NCT04356404 |
Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients |
https://ClinicalTrials.gov/show/NCT04356404 |
Recruiting |
Chinese University of Hong Kong |
2022-05-31 |
| NCT01350648 |
Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection |
https://ClinicalTrials.gov/show/NCT01350648 |
Recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT01263600 |
Hepatitis B Research Network Pediatric Cohort Study (HBRN) |
https://ClinicalTrials.gov/show/NCT01263600 |
Active, not recruiting |
University of Pittsburgh |
2020-09-30 |
| NCT01263587 |
Hepatitis B Research Network Adult Cohort Study |
https://ClinicalTrials.gov/show/NCT01263587 |
Active, not recruiting |
University of Pittsburgh |
2020-09-30 |
| NCT00004850 |
Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection |
https://ClinicalTrials.gov/show/NCT00004850 |
Active, not recruiting |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT02566148 |
Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France |
https://ClinicalTrials.gov/show/NCT02566148 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2012-02-29 |
| NCT02548325 |
Prevalence of Hepatitis B in Vallés Occidental. Observational Multicentric Study |
https://ClinicalTrials.gov/show/NCT02548325 |
Completed |
Corporacion Parc Tauli |
2015-05-31 |
| NCT02533544 |
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02533544 |
Completed |
The Catholic University of Korea |
2018-10-31 |
| NCT02511743 |
Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT02511743 |
Completed |
Peking University First Hospital |
2015-11-30 |
| NCT02443233 |
Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong |
https://ClinicalTrials.gov/show/NCT02443233 |
Completed |
The University of Hong Kong |
2016-12-31 |
| NCT02387463 |
Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT02387463 |
Completed |
Beijing Ditan Hospital |
2017-05-21 |
| NCT02366286 |
Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants |
https://ClinicalTrials.gov/show/NCT02366286 |
Active, not recruiting |
Mayo Clinic |
2022-12-31 |
| NCT02344498 |
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa |
https://ClinicalTrials.gov/show/NCT02344498 |
Active, not recruiting |
Oslo University Hospital |
2020-12-31 |
| NCT02336399 |
Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment |
https://ClinicalTrials.gov/show/NCT02336399 |
Active, not recruiting |
Beijing Ditan Hospital |
2016-12-31 |
| NCT02324218 |
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age |
https://ClinicalTrials.gov/show/NCT02324218 |
Completed |
GlaxoSmithKline |
2015-01-31 |
| NCT02323308 |
Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination |
https://ClinicalTrials.gov/show/NCT02323308 |
Completed |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2014-06-30 |
| NCT02313649 |
ShearWaveâ„¢ Elastography to Assess Liver Fibrosis in Chinese Patients With Hepatitis B |
https://ClinicalTrials.gov/show/NCT02313649 |
Completed |
SuperSonic Imagine |
2016-04-30 |
| NCT02275221 |
Immune Response in Patients With Hepatitis B and C Infection |
https://ClinicalTrials.gov/show/NCT02275221 |
Recruiting |
Basildon and Thurrock University Hospitals NHS Foundation Trust |
2019-12-31 |
| NCT02267473 |
Hepatitis B Patients Under Oral Nucleos(t)Ide Treatment With Intermittent Assessment of Kidney Function |
https://ClinicalTrials.gov/show/NCT02267473 |
Active, not recruiting |
Johann Wolfgang Goethe University Hospital |
2020-10-31 |
| NCT02201407 |
An Observational Study in Participants With Chronic Hepatitis B (CHB) Receiving Therapy With Peginterferon Alfa-2a 40 Kilodaltons (kD) (PEGASYS) - The PRO B Study |
https://ClinicalTrials.gov/show/NCT02201407 |
Completed |
Hoffmann-La Roche |
2017-04-10 |
| NCT02167113 |
Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay |
https://ClinicalTrials.gov/show/NCT02167113 |
Completed |
Hologic, Inc. |
2016-02-29 |
| NCT02129829 |
PROLIFICA - West African Treatment Cohort for Hepatitis B |
https://ClinicalTrials.gov/show/NCT02129829 |
Active, not recruiting |
Imperial College London |
2020-04-01 |
| NCT02125071 |
Study on the Pharmacokinetic Characteristics of I.V. Hepabig Injection Used for Prevention of Hepatitis B Relapse After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT02125071 |
Completed |
Seoul St. Mary’s Hospital |
2015-08-31 |
| NCT02112890 |
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico |
https://ClinicalTrials.gov/show/NCT02112890 |
Completed |
GlaxoSmithKline |
2016-05-02 |
| NCT02108444 |
Hepatitis B Virus Reactivation After Withdrawal of Prophylactic Antiviral Therapy in Lymphoma Patients |
https://ClinicalTrials.gov/show/NCT02108444 |
Completed |
Peking University |
2013-12-31 |
| NCT02075294 |
Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02075294 |
Completed |
Beijing 302 Hospital |
2012-10-31 |
| NCT02069678 |
Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT02069678 |
Completed |
Chinese University of Hong Kong |
2013-09-30 |
| NCT01311947 |
Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01311947 |
Completed |
China Medical University Hospital |
2012-03-31 |
| NCT01311232 |
Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With Rituximab |
https://ClinicalTrials.gov/show/NCT01311232 |
Completed |
Samsung Medical Center |
2012-12-01 |
| NCT01298037 |
HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01298037 |
Active, not recruiting |
University of Pennsylvania |
2021-05-31 |
| NCT01283074 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas) |
https://ClinicalTrials.gov/show/NCT01283074 |
Completed |
Hoffmann-La Roche |
2012-11-30 |
| NCT01282762 |
Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney Disease |
https://ClinicalTrials.gov/show/NCT01282762 |
Completed |
Dynavax Technologies Corporation |
2013-08-31 |
| NCT02044523 |
Noninvasive Staging of Liver Fibrosis: MR vs Ultrasound |
https://ClinicalTrials.gov/show/NCT02044523 |
Completed |
Centre hospitalier de l’Université de Montréal (CHUM) |
2018-06-30 |
| NCT02044068 |
Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women |
https://ClinicalTrials.gov/show/NCT02044068 |
Completed |
Hopital Lariboisière |
2015-09-30 |
| NCT01988753 |
Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases |
https://ClinicalTrials.gov/show/NCT01988753 |
Completed |
Baylor College of Medicine |
2016-06-30 |
| NCT01970254 |
Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy |
https://ClinicalTrials.gov/show/NCT01970254 |
Active, not recruiting |
M.D. Anderson Cancer Center |
2020-12-31 |
| NCT01958229 |
Efficacy Study of Telbivudine in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01958229 |
Completed |
National Taiwan University Hospital |
2012-03-31 |
| NCT01957618 |
The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy |
https://ClinicalTrials.gov/show/NCT01957618 |
Enrolling by invitation |
National Taiwan University Hospital |
2012-01-31 |
| NCT01953458 |
Therapeutic Option for Hepatitis B and C: a French Cohort |
https://ClinicalTrials.gov/show/NCT01953458 |
Recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2022-08-31 |
| NCT01931644 |
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions |
https://ClinicalTrials.gov/show/NCT01931644 |
Recruiting |
Sanguine Biosciences |
2025-08-31 |
| NCT01924455 |
HBV-HIV Coinfection Research Network |
https://ClinicalTrials.gov/show/NCT01924455 |
Completed |
Virginia Commonwealth University |
2019-03-31 |
| NCT01863589 |
Drug Use Investigation for HEPSERA (Adefovir) Tablet |
https://ClinicalTrials.gov/show/NCT01863589 |
Completed |
GlaxoSmithKline |
2007-06-30 |
| NCT01855997 |
A Study to Collect Blood Biomarker Samples From Participants With Chronic Hepatitis B (CHB) Who Received Treatment With Pegasys (Peginterferon Alfa-2a) ± Nucleoside/Nucleotide Analogue |
https://ClinicalTrials.gov/show/NCT01855997 |
Completed |
Hoffmann-La Roche |
2014-11-28 |
| NCT01826760 |
Study of the Model to Predict 3-month Mortality Risk of Acute-on-chronic Hepatitis B Liver Failure |
https://ClinicalTrials.gov/show/NCT01826760 |
Completed |
Wenzhou Medical University |
2010-05-31 |
| NCT01810835 |
Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. |
https://ClinicalTrials.gov/show/NCT01810835 |
Completed |
Hopital Lariboisière |
2013-11-30 |
| NCT01796457 |
HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01796457 |
Active, not recruiting |
University of Pennsylvania |
2020-07-31 |
| NCT01782794 |
Acceptability of Hepatitis B Vaccination in General Population |
https://ClinicalTrials.gov/show/NCT01782794 |
Completed |
GlaxoSmithKline |
2012-06-30 |
| NCT01777074 |
Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians |
https://ClinicalTrials.gov/show/NCT01777074 |
Completed |
GlaxoSmithKline |
2012-04-30 |
| NCT01772121 |
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India |
https://ClinicalTrials.gov/show/NCT01772121 |
Completed |
Gilead Sciences |
2012-10-31 |
| NCT01732354 |
Study for Consolidation Period of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01732354 |
Completed |
Tainan Municipal Hospital |
2013-11-20 |
| NCT01732081 |
“Real-life” Cohort of Patients With Chronic Hepatitis B Virus Infection |
https://ClinicalTrials.gov/show/NCT01732081 |
Recruiting |
University Hospital, Strasbourg, France |
2021-01-31 |
| NCT01730508 |
An Observational Study of Pegasys (Peginterferon Alfa-2a) in Chinese Patients With HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01730508 |
Completed |
Hoffmann-La Roche |
2017-06-25 |
| NCT03350074 |
HBV Envelope Proteins Variability on HBs Antigen Clearance Under Nucleos(t)Ide Analogue Therapy |
https://ClinicalTrials.gov/show/NCT03350074 |
Completed |
Central Hospital, Nancy, France |
2016-05-01 |
| NCT01705704 |
A Retrospective Biomarker Study of Stored Samples Obtained From Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01705704 |
Completed |
Hoffmann-La Roche |
2013-02-28 |
| NCT01667432 |
An Observational Study of Peginterferon Alfa-2a (PEGASYS®) in Patients With HBeAg Positive or HBeAg Negative Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01667432 |
Completed |
Hoffmann-La Roche |
2014-08-12 |
| NCT01645969 |
A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265 |
https://ClinicalTrials.gov/show/NCT01645969 |
Completed |
Hoffmann-La Roche |
2012-10-31 |
| NCT01623778 |
Optimization of Antiviral Therapy of Chronic HBV Infection |
https://ClinicalTrials.gov/show/NCT01623778 |
Completed |
Changhai Hospital |
2011-12-31 |
| NCT01574521 |
Seroepidemiologic Study of Spermatozoal Transmission of Hepatitis B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT01574521 |
Completed |
Taizhou Hospital |
2010-12-31 |
| NCT01548820 |
Resistance to Lamivudine in HBV Egyptian Patients |
https://ClinicalTrials.gov/show/NCT01548820 |
Completed |
Ain Shams University |
2012-11-30 |
| NCT01531166 |
A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon |
https://ClinicalTrials.gov/show/NCT01531166 |
Completed |
Yonsei University |
2014-08-31 |
| NCT01502397 |
Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study |
https://ClinicalTrials.gov/show/NCT01502397 |
Completed |
The University of Hong Kong |
2015-12-31 |
| NCT01500265 |
Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus |
https://ClinicalTrials.gov/show/NCT01500265 |
Completed |
University Hospital, Limoges |
2013-12-31 |
| NCT01481649 |
Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure |
https://ClinicalTrials.gov/show/NCT01481649 |
Completed |
The University of Hong Kong |
2015-02-28 |
| NCT01401400 |
Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study |
https://ClinicalTrials.gov/show/NCT01401400 |
Completed |
Foundation for Liver Research |
2015-06-30 |
| NCT01376154 |
Special Drug Use Investigation for ZEFIX (Lamivudine) Tablet (HBV Cirrhosis) |
https://ClinicalTrials.gov/show/NCT01376154 |
Completed |
GlaxoSmithKline |
2009-12-31 |
| NCT01356901 |
Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT01356901 |
Completed |
Bristol-Myers Squibb |
2015-01-31 |
| NCT01337479 |
A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) Trials |
https://ClinicalTrials.gov/show/NCT01337479 |
Completed |
Bristol-Myers Squibb |
2010-09-30 |
| NCT01329419 |
HEPSERA Post Marketing Surveillance |
https://ClinicalTrials.gov/show/NCT01329419 |
Completed |
GlaxoSmithKline |
2010-02-28 |
| NCT01323452 |
Entecavir for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01323452 |
Completed |
Foundation for Liver Research |
2011-01-31 |
| NCT04310787 |
Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT04310787 |
Recruiting |
Third Affiliated Hospital, Sun Yat-Sen University |
2020-08-15 |
| NCT04264312 |
Baseline Investigation of Chronic Hepatitis B Viruses Infections: Who is Eligible for Treated Criteria |
https://ClinicalTrials.gov/show/NCT04264312 |
Completed |
Centers for Disease Control and Prevention, China |
2019-09-28 |
| NCT04237376 |
Chronic HBV Infection in Pregnant Women Taking TAF to Prevent Vertical Transmission |
https://ClinicalTrials.gov/show/NCT04237376 |
Recruiting |
New Discovery LLC |
2020-09-30 |
| NCT04211805 |
Maternal Therapy With TAF Versus TDF to Prevent Vertical Transmission of Hepatitis B |
https://ClinicalTrials.gov/show/NCT04211805 |
Recruiting |
New Discovery LLC |
2021-09-30 |
| NCT04160897 |
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis |
https://ClinicalTrials.gov/show/NCT04160897 |
Enrolling by invitation |
Ruijin Hospital |
2020-10-31 |
| NCT04135235 |
Effect and Safety of Propofol Fumarate for Mother-to-child Blocking of Hepatitis B |
https://ClinicalTrials.gov/show/NCT04135235 |
Recruiting |
Beijing Ditan Hospital |
2021-08-01 |
| NCT04038372 |
Hepatitis D Virus Infection Among Hepatitis B Virus Surface Antigen Positive Individuals |
https://ClinicalTrials.gov/show/NCT04038372 |
Completed |
Assiut University |
2017-10-31 |
| NCT04030039 |
Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention |
https://ClinicalTrials.gov/show/NCT04030039 |
Recruiting |
Beijing Ditan Hospital |
2020-12-30 |
| NCT04028856 |
Cohort Study of Efficacy and Safety of Interferon Intermittent Treatment of Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT04028856 |
Completed |
Beijing Ditan Hospital |
2019-06-30 |
| NCT03977987 |
Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission |
https://ClinicalTrials.gov/show/NCT03977987 |
Completed |
Huashan Hospital |
2018-12-30 |
| NCT03977857 |
Computed Tomography Liver Volume for Predicting Short-term Mortality in Hepatitis Bâ€Acuteâ€onâ€Chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT03977857 |
Completed |
First Affiliated Hospital Xi’an Jiaotong University |
2019-12-31 |
| NCT03932851 |
Clinical Study on the Effect of IVF-ET on Mother-to-child Transmission of Hepatitis B Virus |
https://ClinicalTrials.gov/show/NCT03932851 |
Recruiting |
Beijing Ditan Hospital |
2019-05-01 |
| NCT03909191 |
Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage |
https://ClinicalTrials.gov/show/NCT03909191 |
Active, not recruiting |
Changhai Hospital |
2020-05-01 |
| NCT03865966 |
Hepatitis B Virus Infection After Liver Transplantation in Children |
https://ClinicalTrials.gov/show/NCT03865966 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2023-12-31 |
| NCT03864263 |
Hepatitis B Virus Infection in Immunized Children With HBsAg-positive Parents |
https://ClinicalTrials.gov/show/NCT03864263 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2020-12-31 |
| NCT03817697 |
Non-vaccination Factors Against Hepatitis B Virus in Drug Users |
https://ClinicalTrials.gov/show/NCT03817697 |
Completed |
Hospices Civils de Lyon |
2019-09-04 |
| NCT03777969 |
Prediction System of Clinical Endpoint Events for Chronic Hepatitis B Patients |
https://ClinicalTrials.gov/show/NCT03777969 |
Recruiting |
Beijing Friendship Hospital |
2020-12-31 |
| NCT03752658 |
TAF Real World Study for Universal Effectiveness |
https://ClinicalTrials.gov/show/NCT03752658 |
Recruiting |
Tongji Hospital |
2023-05-01 |
| NCT03740789 |
Evaluation of Antiviral Indications on Chronic HBV Infection With Different Transaminase Levels |
https://ClinicalTrials.gov/show/NCT03740789 |
Active, not recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2019-04-30 |
| NCT03702998 |
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population |
https://ClinicalTrials.gov/show/NCT03702998 |
Recruiting |
Chinese University of Hong Kong |
2020-07-31 |
| NCT03692897 |
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection |
https://ClinicalTrials.gov/show/NCT03692897 |
Active, not recruiting |
Target PharmaSolutions, Inc. |
2023-01-31 |
| NCT03643172 |
Terminator 2 Register |
https://ClinicalTrials.gov/show/NCT03643172 |
Recruiting |
Hannover Medical School |
2020-07-31 |
| NCT03642340 |
A Post-marketing Surveillance to Assess Safety and Efficacy of Besivo |
https://ClinicalTrials.gov/show/NCT03642340 |
Recruiting |
IlDong Pharmaceutical Co Ltd |
2023-05-14 |
| NCT03640728 |
The Efficacy and Safety of Nucleos(t)Ide Analogues in the Treatment of HBV-related Acute-on-chronic Liver Failure |
https://ClinicalTrials.gov/show/NCT03640728 |
Recruiting |
First Affiliated Hospital Xi’an Jiaotong University |
2021-04-30 |
| NCT03625258 |
Mutations of the Pre-core Region of Hepatite B Virus (HBV) |
https://ClinicalTrials.gov/show/NCT03625258 |
Completed |
Centre Hospitalier Universitaire, Amiens |
2017-02-01 |
| NCT03587467 |
Study on Gut Microbiota in Chronic HBV Infected Patients |
https://ClinicalTrials.gov/show/NCT03587467 |
Recruiting |
Zhongshan Hospital Xiamen University |
2020-12-01 |
| NCT03579576 |
Simplified Antiviral Treatment Strategy for Hepatitis C in Myanmar |
https://ClinicalTrials.gov/show/NCT03579576 |
Completed |
Right to Care |
2019-03-30 |
| NCT03559790 |
Treatment Efficacy and Safety of TDF-TAF Switch Study in South Korea |
https://ClinicalTrials.gov/show/NCT03559790 |
Recruiting |
The Catholic University of Korea |
2020-08-31 |
| NCT03529760 |
Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia |
https://ClinicalTrials.gov/show/NCT03529760 |
Recruiting |
Children’s Hospital of Chongqing Medical University |
2019-07-15 |
| NCT03511794 |
Effectiveness of the Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant |
https://ClinicalTrials.gov/show/NCT03511794 |
Enrolling by invitation |
National Institutes of Health Clinical Center (CC) |
2021-06-01 |
| NCT03459768 |
Cohort Study on People Who Inject Drugs in Senegal |
https://ClinicalTrials.gov/show/NCT03459768 |
Active, not recruiting |
French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS) |
2020-02-29 |
| NCT03426618 |
A Real-World Observational Study for the Safety and Efficacy of Baraclude in Korean Pediatric Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT03426618 |
Completed |
Bristol-Myers Squibb |
2019-03-13 |
| NCT03425513 |
Hepatitis B Virus Prevalence and Risk Factors in Belgium |
https://ClinicalTrials.gov/show/NCT03425513 |
Completed |
Hasselt University |
2017-11-27 |
| NCT01267162 |
Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients |
https://ClinicalTrials.gov/show/NCT01267162 |
Completed |
Medical Procare PLLC |
2013-11-30 |
| NCT01264107 |
An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine |
https://ClinicalTrials.gov/show/NCT01264107 |
Completed |
Bukwang Pharmaceutical |
2012-01-31 |
| NCT01163240 |
Epidemiological Study in Children and Adolescents With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01163240 |
Completed |
Novartis |
2011-09-30 |
| NCT01155427 |
Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB) |
https://ClinicalTrials.gov/show/NCT01155427 |
Completed |
Bristol-Myers Squibb |
2010-04-30 |
| NCT01128686 |
Lamivudine(LAM) Good Responder Study |
https://ClinicalTrials.gov/show/NCT01128686 |
Completed |
ViiV Healthcare |
2011-06-30 |
| NCT01107483 |
Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT01107483 |
Completed |
Sun Yat-sen University |
2010-02-28 |
| NCT01105559 |
Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine |
https://ClinicalTrials.gov/show/NCT01105559 |
Completed |
Sanofi |
2011-11-30 |
| NCT01090531 |
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy |
https://ClinicalTrials.gov/show/NCT01090531 |
Active, not recruiting |
Johann Wolfgang Goethe University Hospital |
2021-08-31 |
| NCT01011738 |
An Observational Cohort Study in Patients With Chronic Hepatitis B Receiving Pegasys |
https://ClinicalTrials.gov/show/NCT01011738 |
Completed |
Hoffmann-La Roche |
2014-11-18 |
| NCT00970216 |
Study of Telbivudine in Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00970216 |
Completed |
Chang Gung Memorial Hospital |
2016-01-31 |
| NCT00956891 |
Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs Transplantation |
https://ClinicalTrials.gov/show/NCT00956891 |
Completed |
Sun Yat-sen University |
2009-06-30 |
| NCT00946010 |
Investigation of Hepatitis B and Hepatitis C in Taiwan |
https://ClinicalTrials.gov/show/NCT00946010 |
Completed |
National Taiwan University Hospital |
2010-08-31 |
| NCT00881036 |
Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive Patients |
https://ClinicalTrials.gov/show/NCT00881036 |
Completed |
Kyoto University |
2015-07-31 |
| NCT00876148 |
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting |
https://ClinicalTrials.gov/show/NCT00876148 |
Completed |
Azienda Ospedaliera San Giovanni Battista |
NA |
| NCT00873652 |
Observational Study of Immune Response to Hepatitis B Childhood Booster |
https://ClinicalTrials.gov/show/NCT00873652 |
Completed |
University of Oxford |
2011-01-31 |
| NCT02019966 |
A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy |
https://ClinicalTrials.gov/show/NCT02019966 |
Completed |
Yonsei University |
2017-08-04 |
| NCT01581554 |
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT01581554 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03345498 |
Entecavir for Decompensated HBV Cirrhosis |
https://ClinicalTrials.gov/show/NCT03345498 |
Completed |
Sanjay Gandhi Postgraduate Institute of Medical Sciences |
2018-06-30 |
| NCT02005146 |
Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs |
https://ClinicalTrials.gov/show/NCT02005146 |
Completed |
Andalusian Network for Design and Translation of Advanced Therapies |
2014-12-31 |
| NCT01182311 |
Duration of Long-term Immunity After Hepatitis B Virus Immunization |
https://ClinicalTrials.gov/show/NCT01182311 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT03528941 |
The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib |
https://ClinicalTrials.gov/show/NCT03528941 |
Recruiting |
Gruppo Italiano Malattie EMatologiche dell’Adulto |
2020-08-31 |
| NCT03155984 |
Optimizing HBV Management During Anti-CD20 Antibodies |
https://ClinicalTrials.gov/show/NCT03155984 |
Completed |
The University of Hong Kong |
2017-06-01 |
| NCT02060162 |
Antiretroviral Treatment Outcomes in HIV-HBV Co-infected Patients in Southern Africa |
https://ClinicalTrials.gov/show/NCT02060162 |
Active, not recruiting |
University of Alabama at Birmingham |
2021-06-30 |
| NCT03181113 |
Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy |
https://ClinicalTrials.gov/show/NCT03181113 |
Enrolling by invitation |
Xiamen Amoytop Biotech Co., Ltd. |
2020-12-31 |
| NCT04032275 |
Correlation Between Virus and Biochemical Characteristics and Liver Histological Damage in Untreated Chronic HBV Infection |
https://ClinicalTrials.gov/show/NCT04032275 |
Completed |
Beijing Ditan Hospital |
2018-12-30 |
| NCT00782158 |
Hepatitis B and HIV Co-Infection in Patients in Uganda |
https://ClinicalTrials.gov/show/NCT00782158 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |
| NCT00769730 |
Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication |
https://ClinicalTrials.gov/show/NCT00769730 |
Completed |
Kaohsiung Medical University Chung-Ho Memorial Hospital |
2009-02-28 |
| NCT00645736 |
CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study |
https://ClinicalTrials.gov/show/NCT00645736 |
Completed |
Gilead Sciences |
2008-10-31 |
| NCT00512941 |
Laboratory Profile of Hepatitis B and C in Users of a Reference Service |
https://ClinicalTrials.gov/show/NCT00512941 |
Completed |
UPECLIN HC FM Botucatu Unesp |
NA |
| NCT00476723 |
HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infection |
https://ClinicalTrials.gov/show/NCT00476723 |
Completed |
The HIV Netherlands Australia Thailand Research Collaboration |
2007-12-31 |
| NCT00404989 |
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant Women. |
https://ClinicalTrials.gov/show/NCT00404989 |
Recruiting |
Syneos Health |
2099-01-31 |
| NCT00388674 |
Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection |
https://ClinicalTrials.gov/show/NCT00388674 |
Completed |
Bristol-Myers Squibb |
2016-10-26 |
| NCT00381992 |
Risk Assessment of Long-Haul Truck Drivers |
https://ClinicalTrials.gov/show/NCT00381992 |
Completed |
Wake Forest University Health Sciences |
2010-03-31 |
| NCT00362674 |
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial |
https://ClinicalTrials.gov/show/NCT00362674 |
Completed |
Bukwang Pharmaceutical |
NA |
| NCT00912847 |
Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma |
https://ClinicalTrials.gov/show/NCT00912847 |
Completed |
Chinese University of Hong Kong |
2004-04-30 |
| NCT00361179 |
Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C |
https://ClinicalTrials.gov/show/NCT00361179 |
Completed |
National Taiwan University Hospital |
NA |
| NCT00342186 |
Genes Involved in Resistance or Susceptibility to Hepatitis B Virus |
https://ClinicalTrials.gov/show/NCT00342186 |
Completed |
National Institutes of Health Clinical Center (CC) |
2018-02-22 |
| NCT00263614 |
Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases. |
https://ClinicalTrials.gov/show/NCT00263614 |
Completed |
Gilead Sciences |
NA |
| NCT00199732 |
Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a |
https://ClinicalTrials.gov/show/NCT00199732 |
Completed |
University Hospital, Limoges |
2009-07-31 |
| NCT00168194 |
Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History |
https://ClinicalTrials.gov/show/NCT00168194 |
Completed |
The Alfred |
NA |
| NCT00161941 |
Follow-up Study on the Antibody Response to Hepatitis B, Acellular Pertussis Toxin and Inactivated Poliovirus Antigens 1 Month After the 4th Hexavac® Vaccination in Healthy Children, Who Participated in NeisVac-C Study 216 |
https://ClinicalTrials.gov/show/NCT00161941 |
Completed |
Pfizer |
NA |
| NCT00158717 |
Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV. |
https://ClinicalTrials.gov/show/NCT00158717 |
Completed |
Gilead Sciences |
2006-04-30 |
| NCT00155155 |
Studies of Immune Responses in Patients With Chronic Hepatitis B |
https://ClinicalTrials.gov/show/NCT00155155 |
Completed |
National Taiwan University Hospital |
2008-04-30 |
| NCT00146835 |
Post-marketing Safety Study of GSK Biological’s Pediarixâ„¢ Vaccine |
https://ClinicalTrials.gov/show/NCT00146835 |
Completed |
GlaxoSmithKline |
2006-06-30 |
| NCT00146705 |
Long Term Follow-up of Pegylated-Interferon Alpha-2b |
https://ClinicalTrials.gov/show/NCT00146705 |
Completed |
Foundation for Liver Research |
NA |
| NCT00142740 |
Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025 |
https://ClinicalTrials.gov/show/NCT00142740 |
Completed |
University of North Carolina, Chapel Hill |
2008-06-30 |
| NCT00141999 |
Response to Booster Doses of Hepatitis B Vaccine in Children and Adolescents |
https://ClinicalTrials.gov/show/NCT00141999 |
Completed |
Centers for Disease Control and Prevention |
2005-03-31 |
| NCT00138268 |
Pilot Study Freeze and Transport Immune Cells |
https://ClinicalTrials.gov/show/NCT00138268 |
Completed |
National Institute of Allergy and Infectious Diseases (NIAID) |
NA |
| NCT00097006 |
Retrovirus Epidemiology Donor Study-II (REDS-II) |
https://ClinicalTrials.gov/show/NCT00097006 |
Completed |
National Heart, Lung, and Blood Institute (NHLBI) |
2009-09-30 |
| NCT00059267 |
Prevention of Recurrent Hepatitis B After Liver Transplantation |
https://ClinicalTrials.gov/show/NCT00059267 |
Completed |
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
2007-11-30 |
| NCT00001712 |
Frequency of Parenteral and Non-Parenteral Exposures to Blood Among Healthcare Workers at the Clinical Center, NIH and at Seven Academic Hospitals in Japan |
https://ClinicalTrials.gov/show/NCT00001712 |
Completed |
National Institutes of Health Clinical Center (CC) |
NA |